Viral Hepatitis Becomes Leading Cause of Death in the World

With a number of people turning victims to chronic diseases such as AIDS, tuberculosis or malaria, a recent review report revealed that viral hepatitis had become a leading cause of death and disability in the world, killing more people in a year than other diseases.

Deaths from infection, liver disease and cancer caused by viral hepatitis increased by 63 percent from 890,000 in 1990 to 1.45 million in 2013, according to a review of data collected in 183 countries.

Treating Hepatitis C at Earlier Stage is Cheaper and Could Save Lives
Treating hepatitis C patients could save $800 billion in the next 20 years and free up treatment for thousands of people with other liver diseases.

‘Deaths due to viral hepatitis have increased by 63 percent from 890,000 in 1990 to 1.45 million in 2013, surpassing the number of fatalities caused by other leading diseases such as AIDS, tuberculosis and malaria.’

Tweet it Now

By comparison, in 2013 there were 1.3 million deaths from AIDS, 1.4 million from tuberculosis, and 855,000 from malaria, said the report, published in The Lancet.

"Whereas deaths from many infectious diseases -- such as TB and malaria -- have dropped since 1990, viral hepatitis deaths have risen," said study leader Graham Cooke from Imperial College London's medicine department.

Hepatitis is an inflammation of the liver, most often caused by a virus but sometimes by drug or alcohol abuse, other infections, or autoimmune diseases. There are five main types, known as A, B, C, D and E.

Tackling Hepatitis C Infection Through Emergency Department Testing
Hepatitis C testing in the emergency department at the University of Alabama at Birmingham Hospital has identified 2,436 positive cases since testing began in September 2013.

According to the World Health Organization, types A and E are typically transmitted via contaminated food or water, while B, C and D usually occur from contact with body fluids of an infected person.

An estimated 95 percent of people are unaware of their infection, though treating hepatitis B and C can prevent the development of chronic liver disease.

Indian Scientists Develop World�s First Oral Vaccine for Hepatitis B
AIIMS researchers developed nanoparticles loaded with antigen protein that shows promise for an oral vaccine against the hepatitis-B virus.

Ninety-six percent of hepatitis deaths counted in the review were caused by types B and C, said the researchers. Most hepatitis deaths occurred in east and south Asia.

"We have tools at our disposal to treat this disease -- we have vaccines to hepatitis A and B and we have new treatments to C," for which there is no vaccine, said Cooke.

Obese Teens Have Higher Risk of Developing Severe Liver Diseases
It has been estimated that there will be more than two billion overweight and over one billion obese individuals worldwide by 2030.

"However the price of new medicines is beyond the reach of any country -- rich or poor."

The review concluded with a call for a change in funding structures to "allow effective responses in low-income and lower-middle-income countries."

Source-AFP